HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jorge de la Rosa Selected Research

Cyclin-Dependent Kinase Inhibitor p16

3/2013Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jorge de la Rosa Research Topics

Disease

3Neoplasms (Cancer)
11/2015 - 11/2010
2Progeria (Hutchinson Gilford Syndrome)
01/2013 - 06/2011
1Glioma (Gliomas)
01/2020
1Carcinogenesis
11/2015
1Hepatocellular Carcinoma (Hepatoma)
11/2015
1Cholangiocarcinoma
11/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2013
1Squamous Cell Carcinoma of Head and Neck
03/2013
1Melanoma (Melanoma, Malignant)
03/2013
1Carcinoma (Carcinomatosis)
01/2013

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
01/2020
1epidermal growth factor receptor VIIIIBA
01/2020
1Investigational DrugsIBA
01/2020
1CRISPR-Cas Systems Guide RNAIBA
11/2015
1ChromatinIBA
11/2015
1Proteins (Proteins, Gene)FDA Link
11/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
03/2013
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
03/2013
1Cyclin-Dependent Kinase Inhibitor p16IBA
03/2013
1prelamin AIBA
01/2013
1Lamin Type A (Lamin A)IBA
01/2013
1Metalloproteases (Metalloproteinases)IBA
01/2013
1MicroRNAs (MicroRNA)IBA
06/2011
1TransposasesIBA
11/2010

Therapy/Procedure

1Therapeutics
01/2013